Indian Journal of Anaesthesia  
About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions
Home | Login  | Users Online: 123  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size    




 
CLINICAL INVESTIGATION
Year : 2010  |  Volume : 54  |  Issue : 4  |  Page : 302-307 Table of Contents     

Acute aluminium phosphide poisoning: Can we predict mortality?


Department of Anaesthesiology & Critical Care, Christian Medical College and Hospital, Ludhiana, Punjab, India

Date of Web Publication12-Aug-2010

Correspondence Address:
Ashu Mathai
Department of Anaesthesiology and Critical Care, Christian Medical College & Hospital, Ludhiana - 141 008, Punjab
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-5049.68372

Rights and Permissions
 

In India, acute aluminium phosphide poisoning (AAlPP) is a serious health care problem. This study aimed to determine the characteristics of AAlPP and the predictors of mortality at the time of patients' admission. We studied consecutive admissions of patients with AAlPP admitted to the intensive care unit (ICU) between November 2004 and October 2006. We noted 38 parameters at admission to the hospital and the ICU and compared survivor and non-survivor groups. A total of 27 patients were enrolled comprising5 females and 22 males and the mean ingested dose of poison was 0.75 ± 0.745 grams. Hypotension was noted in 24 patients (89%) at admission and electrocardiogram abnormalities were noted in 13 patients (48.1%). The mean pH on admission was 7.20 ± 0.14 and the mean bicarbonate concentration was 12.32 ± 5.45 mmol/ L. The mortality from AAlPP was 59.3%. We found the following factors to be associated with an increased risk of mortality: a serum creatinine concentration of more than 1.0 mg % (P = 0.01), pH value less than 7.2 (P = 0.014), serum bicarbonate value less than 15 mmol/L (P = 0.048), need for mechanical ventilation (P = 0.045), need for vasoactive drugs like dobutamine (P = 0.027) and nor adrenaline (P = 0.048) and a low APACHE II score at admission (P = 0.019). AAlPP causes high mortality primarily due to early haemodynamic failure and multi-organ dysfunction

Keywords: Aluminium phosphide, mortality, poisoning


How to cite this article:
Mathai A, Bhanu MS. Acute aluminium phosphide poisoning: Can we predict mortality?. Indian J Anaesth 2010;54:302-7

How to cite this URL:
Mathai A, Bhanu MS. Acute aluminium phosphide poisoning: Can we predict mortality?. Indian J Anaesth [serial online] 2010 [cited 2016 Sep 27];54:302-7. Available from: http://www.ijaweb.org/text.asp?2010/54/4/302/68372


   Introduction Top


Acute aluminium phosphide poisoning (AAlPP) is a large, though under-reported, problem in the Indian subcontinent. Aluminium phosphide is reported to be highly toxic when consumed from a freshly opened container and the fatal dose for an average sized individual is believed to be 150 to 500 grams. [1] Death is reported to result from profound shock, myocarditis and multiorgan failure.

The mortality rates from AAlPP published in literature vary from 40-80%. [1] However, the actual numbers of cases affected are much larger, as less than 5% of those with AAlPP eventually reach a tertiary care centre. [2] Since 1992, when aluminium phosphide became freely available in the market, it has reportedly, overtaken all other forms of deliberate poisoning like organophosphorus and barbiturate poisoning in northern India. [3] In their 25 year study on 5,933 unnatural case fatalities in north-west India by Singh D et al., AAlPP was the major cause of death among all poisonings. [4]

Despite these large numbers, there has been little progress in our understanding of the characteristics of the poison and limited Indian data is available on the predictors of mortality in these patients. The purpose of this study was to retrospectively study the profile of patients presenting with AAlPP and to identify the factors at admission that might be useful in predicting mortality.


   Methods Top


Study design

All consecutive cases of AAlPP presenting to a tertiary care hospital in northern India over a two-year period from November 2004 to October 2006 were retrospectively reviewed. The diagnosis of AAlPP was based on history of consumption of the poison (obtained from the patient or the closest relative) and symptomatology at admission. Instances where the patients had presented with an unclear diagnosis of poisoning or where there was consumption of more than one substance were excluded from the study.

All patients were admitted into our ICU after initial resuscitation and gastric lavage. A baseline electrocardiogram was recorded and blood samples for biochemical and haematological investigations were sent from the emergency room within an hour of presentation to the hospital. Infusion of vasoactive agents and mechanical ventilatory support were instituted where indicated. We collected 38 variables, like age, gender, nature of poisoning (suicidal/accidental), the dose and characteristics of the poison consumed (exposed/unexposed form) and the delay in presentation to hospital. The nature of any first aid instituted before reaching this hospital as well as laboratory parameters on admission to the hospital and ICU were also noted. The severity of the poisoning was assessed from the extent of organ dysfunction (renal, hepatic, neurological, gastrointestinal, cardiovascular, etc.), the need for mechanical ventilation and the requirement of drugs for vasoactive support. We also calculated severity of illness scores like APACHE II (Acute Physiology and Chronic Health Evaluation) and SAPS II (Simplified Acute Physiology Score) on all patients based on the data available [Table 1].
Table 1 :Variables collected on patients presenting with aluminium phosphide poisoning


Click here to view


Statistical analysis

The SPSS computer program was used to process the data and generate the statistics. Univariate analysis was performed to compare survivors with non survivors groups (P < 0.05 was considered significant).


   Results Top


A total of 27 patients with AAlPP were admitted into our ICU during the study period. The majority of patients were young and in the age group from 21 to 40 years [Figure 1] with males outnumbering females by more than 4:1.
Figure 1 :Age distribution of patients with acute aluminium phosphide poisoning. The majority of victims were young, in the age group of 21 to 40 years

Click here to view


Most of the cases involved suicidal consumption of the poison (92%) and 60% of the poison was consumed in the unexposed form of the tablet and an average of 1.53 grams of drug was consumed. There was a mean delay of 2.1 ± 1.55 hours before presenting to this hospital. There was no significant association between the dose of poison consumed or the time delay in presentation to the hospital with mortality. We also did not find any association between consumption of the poison in its unexposed form and mortality (P = 0.922) [Table 2].
Table 2 :Demographic profile: The demographic profile of patients presenting with acute aluminium phosphide poisoning were comparable between survivors and non-survivors


Click here to view


At presentation to the hospital, the most predominant feature experienced by patients was vomiting and nausea (92.6%). A few patients had respiratory distress (7%). The mean Glasgow coma scale at admission was 13.29 ± 2.825 and the mean partial pressure of oxygen in arterial blood (paO 2 ) and partial pressure of carbon dioxide in arterial blood (paCO 2 ) in patients were 72.63 ± 4.06 mm Hg and 26.37 ± 7.46 mm Hg, respectively. A total of 7 patients (25%) had high serum creatinine values at admission, all of whom eventually died. Serum creatinine levels were found to correlate well with mortality. Survivors had significantly lower serum creatinine levels at admission as compared to non- survivors (0.82 ± 0.1418 milligram per deciliter versus 1.375 ± 0.642 milligram per deciliter respectively, P = 0.011). The mean pH of patients at admission too, was a good indicator of prognosis. Survivors had a much higher average value (7.284 ± 0.151) than non-survivors (7.148 ± 0.120) and this difference was statistically significant (P = 0.015). Similarly, serum bicarbonate levels at admission also correlated well with the eventual outcome in these patients (P = 0.048). All patients had normal levels of sodium at admission to the hospital while 48% of patients had hypokalemia. These variables were statistically insignificant. Increased serum levels of bilirubin, aspartate aminotranferase, alanine aminotransferase and random blood sugar at admission did not show any association with mortality. The salient clinical investigations noted at admission are as given in [Table 3].
Table 3 :Relevant clinical investigations at admission in patients with acute aluminium phosphide poisoning


Click here to view


We found that 81% of patients had cardiac symptoms, mainly in the form of hypotension and/or arrhythmias on admission to the hospital. A total of 13 patients had dysrhythmias at admission, of which, the majority (69%) were of supraventricular origin [Figure 2]. Though the presence of electrocardiographic abnormalities did not predict mortality, there was a trend towards increasing mortality in patients with dysrhythmias (P = 0.07).
Figure 2 :ECG abnormalities at admission. Most of the dysrhythmias were supraventricular. Presence of dysrhythmias showed a trend towards increasing mortality

Click here to view


Immediately on admission into the intensive care unit, 50% of the patients required mechanical ventilatory support while non invasive ventilation was used only in one patient. Eighty nine percent of the patients were in shock at admission despite adequate fluid resuscitation and needed vasoactive support, predominantly dobutamine and nor adrenaline. In all patients, magnesium sulphate was used for treatment while systemic steroid therapy (injectable hydrocortisone) was initiated in 70% of patients (mainly depending on the treating physician).

The mean APACHE II score at admission to the hospital was 12.14 ± 6.608 and SAPS II score was 31.44 ± 14.781 [Figure 3] and [Figure 4]. We found that, in patients with APACHE II scores of more than 8, the rates of mortality were 73% and in patients with SAPS II scores of more than 30, the mortality rates were 69.2%. The APACHE II score at admission correlated well with mortality and survivors had significantly lower score than non-survivors (score 8.64 ± 5.27 vs 14.56 ± 6.66, respectively, P = 0.019). The SAPS II score did not show the same degree of significance, though the average score was higher in non-survivors. (26.36 ± 13.66 versus 34.94 ± 15.58 in survivors and non-survivors respectively, P = 0.142) [Table 4].
Table 4 :Factors evaluated for prediction of mortality in patients with acute aluminium phosphide poisoning (univariate analysis)


Click here to view
Figure 3 :Correlation of APACHE II score with mortality. The APACHE II score predicted mortality with good accuracy. The scores were significantly different between survivors and non-survivors. In patients with APACHE II scores of more than 8, mortality was 73%

Click here to view
Figure 4 :Correlation of SAPS II score with mortality. Though the SAPS II score did not show a significant difference between survivors and non- survivors, in patients with SAPS II score of more than 30, the mortality rate was 69.2%

Click here to view


The overall mortality from AAlPP poisoning in our unit during the study period was 59.3%. The statistically significant factors useful in predicting mortality in our study were, an elevated serum creatinine concentration (P = 0.01) at admission, need for mechanical ventilation (P = 0.045), need for vasoactive drugs like dobutamine (P = 0.027) and nor adrenaline (P = 0.048), pH value less than 7.2 (P = 0.014), a low serum bicarbonate value (P = 0.048) and a high APACHE II score (P = 0.019).


   Discussion Top


Aluminium Phosphide is an extremely toxic compound and resulted in a high mortality rate of 59.3% in our study. The toxicity of Aluminium Phosphide is attributed to the liberation of phosphine gas which is cytotoxic and causes free radical mediated injury.



Phosphine a nucleophile, acts as a strong reducing agent capable of inhibiting cellular enzymes involved in several metabolic processes. Early studies on phosphine demonstrated specific inhibitory effects on mitiochondrial cytochrome c oxidase. [5] Experimental and observational studies have subsequently demonstrated that the inhibition of cytochrome c oxidase and other enzymes leads to the generation superoxide radicals and cellular peroxides. Cellular injury subsequently occurs through lipid peroxidation and other oxidant mechanisms. [6],[7] Chugh et al. reported that, serum phosphine levels correlate positively with the severity of poisoning and levels equal to or less than 1.067 ± 0.16 mg % appear to be the limit of phosphine toxicity. [8] The major lethal consequence of aluminium phosphide ingestion i.e., profound circulatory collapse, is reportedly secondary to these toxins generated, which lead to direct effects on cardiac myocytes, fluid loss, and adrenal gland damage. [9] In addition, phosphine also has corrosive effects on tissues. [9]

As less than 5% of patients with AAlPP eventually reach a tertiary care hospital, it is extremely difficult to know the actual incidence of these poisonings in our country and it is postulated that the spectrum of actual cases may be much larger than that reported. In one study of 559 cases of all acute poisonings presenting over 14 months, aluminium phosphide was found to be the commonest poison consumed (79.8%) in the Haryana- Rohtak belt with a mortality of 67.6%. [10]

In our study we found that most of the victims were young with males outnumbering females. As with other poisonings, aluminium phosphide is a common method of attempting suicide among the younger, productive age group of society. The patients in our study typically developed gastrointestinal symptoms early in their presentation and the predominant early toxic manifestation was cardiac (hypotension and arrhythmias). Most patients needed some form of vasopressor/ionotrope support and the need to use these early after admission was clearly associated with a poorer outcome.

In their study on 418 patients, with aluminium phosphide poisoning over seven years, Chugh et al. reported gastrointestinal symptoms as the commonest while conduction disturbances and arrhythmias occurred in 38% of patients and an overall mortality rate of 77%. [11]

The management of AAlPP remains purely supportive. Though magnesium sulphate was used in the treatment of all our patients, there is conflicting data in literature on the role of magnesium sulphate in the treatment of acute aluminium phosphide poisoning. Some studies seem to suggest that there is hypomagnesaemia associated with AAlPP and that there is a direct relationship between abnormal electrocardiographic findings and low magnesium levels. They report reduced mortality rates with magnesium therapy in these patients. [12],[13] However other studies have shown no such benefits and some have even demonstrated hypermagnesaemia in patients with AAlPP. [14] In their study on the role of magnesium in such patients, Siwach et al., reported that there was no evidence of hypomagnesaemia in these patients nor did magnesium sulphate therapy improve survival. [15]

We found six factors that can be assessed at admission to the hospital to predict mortality from aluminium phosphide ingestion. These include an elevated serum creatinine concentration, a low pH value (less than 7.2), a low serum bicarbonate value (less than 15), a low APACHE II score, an early need for mechanical ventilation and for vasoactive drugs like dobutamine and nor adrenaline for haemodynamic support. These findings are similar to that obtained by Louriz et al., who concluded that the prognostic factors associated with mortality from AAlPP, included a low APACHE II score, low Glasgow coma scale score, shock, electrocardiogram abnormalities, the presence of acute renal failure, low prothrombin rate, hyperleukocytosis, use of vasoactive drugs and use of mechanical ventilation. [16] In a recent update on AAlPP by Wahab, et al., the development of refractory shock, ARDS, aspiration pneumonitis, anaemia, metabolic acidosis, electrolyte imbalance, coma, severe hypoxia, gastrointestinal bleeding, and pericarditis were the factors reportedly associated with poor prognosis. They also noted that the outcome from AAlPP correlates best with the number of vomiting the patient gets after ingestion and the severity of hypotension that the patient develops. [17]

The limitation of our study was that it was retrospectively designed. Hence, larger prospective studies need to be done in the future to conclusively support our results.

We conclude that aluminium phosphide is an extremely toxic compound with mortality close to 60%. The variables at admission which could be used to detect patients at greater risk of mortality from AAlPP include, need for mechanical ventilation, hypotension at admission requiring vasoactive drugs, low pH values, low serum bicarbonate levels, low serum creatinine levels and low APACHE II scores.


   Acknowledgement Top


We would like to acknowledge that the data presented here was used in a poster at the Annual Conference of Indian Society of Critical Care Medicine, Cochin, January 2007.

 
   References Top

1.Chugh SN, Dushayant K, Ram S, Arora B. Incidence and outcome of aluminium phosphide poisoning in a hospital study. Indian J Med Res 1991;94:232-35.  Back to cited text no. 1      
2.Chugh SN. Aluminium phosphide poisoning. J Indian Acad Med 1999;4:83-9.  Back to cited text no. 2      
3.Singh D, Jit I, Tyagi S. Changing Trends in Acute Poisoning in Chandigarh Zone: A 25-Year Autopsy Experience From a Tertiary Care Hospital in Northern India. Am J Forensic Med Pathol 1999;20:203-10.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Singh D, Dewan I, Pandey AN, Tyagi S. Spectrum of unnatural fatalities in the Chandigarh zone of north-west India- a 25-year autopsy study from a tertiary care hospital. J Clin Forensic Med 2003;10:145-52.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Chefurka W, Kashi KP, Bond EJ. The effect of phosphine (gas toxic to insects) on electron transport in mitochondria. Pestic Biochem Physiol 1976;6:65-84.  Back to cited text no. 5      
6.Bolter CJ, Chefurka W. Extramitochondrial release of hydrogen peroxide from insect and mouse liver mitochondria using the respiratory inhibitors phosphine myxothiazol, and antimycin and spectral analysis of inhibited cytochromes. Arch Biochem Biophys 1990;278:65-72.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]  
7.Chugh SN, Arora V, Sharma A, Chugh K. Free radical scavengers and lipid peroxidation in acute aluminium phosphide poisoning. Indian J Med Res 1996;104:190-3.  Back to cited text no. 7  [PUBMED]    
8.Chugh SN, Pal R, Singh V, Seth S. Serial blood phosphine levels in acute aluminium phosphide poisoning. J Assoc Physicians India 1996;44:184-5.  Back to cited text no. 8  [PUBMED]    
9.Alex T. Proudfoot. Aluminium and zinc phosphide poisoning. Clin Toxicol 2009;47:89-100.  Back to cited text no. 9      
10.Siwach SB, Gupta A. The profile of acute poisonings in Harayana-Rohtak study. J Assoc Physicians India 1995;43:756-9.  Back to cited text no. 10  [PUBMED]    
11.Chugh SN, Dushyant, Ram S, Arora B, Malhotra KC. Incidence and outcome of aluminium phosphide poisoning in a hospital study. Indian J Med Res 1991;94:232-5.  Back to cited text no. 11  [PUBMED]    
12.Chugh SN, Kolley T, Kakkar R, Chugh K, Sharma A. A critical evaluation of anti-peroxidant effect of intravenous magnesium in acute aluminium phosphide poisoning. Magnes Res 1997;10:225-30.  Back to cited text no. 12  [PUBMED]    
13.Chugh SN, Jaggal KL, Sharma A, Arora B, Malhotra KC. Magnesium levels in acute cardiotoxicity due to aluminium phosphide poisoning. Indian J Med Res 1991;94:437-9.   Back to cited text no. 13  [PUBMED]    
14.Singh RB, Singh RG, Singh U. Hypermagnesemia following aluminium phosphide poisoning. Int J Clin Pharmacol Ther Toxicol 1991;29:82-5.  Back to cited text no. 14  [PUBMED]    
15.Siwach SB, Singh P, Ahlawat S, Dua A, Sharma D. Serum and tissue magnesium content in patients of aluminium phosphide poisoning and critical evaluation of high dose magnesium sulphate therapy in reducing mortality. J Assoc Physicians India 1994;2:107-10.  Back to cited text no. 15      
16.Louriz M, Dendane T, Abidi K, Madani N, Abouqal R, Zeggwagh AA. Prognostic factors of acute aluminum phosphide poisoning. Indian J Med Sci 2009;63:227-34.  Back to cited text no. 16  [PUBMED]  Medknow Journal  
17.A Wahab, MS Zaheer, S Wahab, RA Khan. Acute aluminium phosphide poisoning: an update. Hong Kong J Emerg Med 2008;15:152-5.  Back to cited text no. 17      


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]


This article has been cited by
1 Rice tablet: An overview to common material in Iran
Hassan Amiri,Leila Vaseie,Paria Habibollahi,Niloufar Ghodrati,Seied Mohammad Hoseini-Kasnavieh
Journal of Analytical Research in Clinical Medicine. 2016; 4(2): 77
[Pubmed] | [DOI]
2 Aluminum Phosphide Poisoning-Related Deaths in Tehran, Iran, 2006 to 2013
Afshar Etemadi-Aleagha,Maryam Akhgari,Fariba Sardari Iravani
Medicine. 2015; 94(38): e1637
[Pubmed] | [DOI]
3 Acute phosphine poisoning on board a bulk carrier: analysis of factors leading to a fatal case
Brice Loddé,David Lucas,Jean-Marie Letort,Dominique Jegaden,Richard Pougnet,Jean-Dominique Dewitte
Journal of Occupational Medicine and Toxicology. 2015; 10(1)
[Pubmed] | [DOI]
4 Zinc Phosphide Poisoning
Erdal Dogan,Abdulmenap Güzel,Taner Çiftçi,Ilker Aycan,Feyzi Çelik,Bedri Çetin,Gönül Ölmez Kavak
Case Reports in Critical Care. 2014; 2014: 1
[Pubmed] | [DOI]
5 Simplified Acute Physiology Score II/Acute Physiology and Chronic Health Evaluation II and Prediction of the Mortality and Later Development of Complications in Poisoned Patients Admitted to Intensive Care Unit
Afshin Mohammad Alizadeh,Hossein Hassanian-Moghaddam,Shahin Shadnia,Nasim Zamani,Omid Mehrpour
Basic & Clinical Pharmacology & Toxicology. 2014; : n/a
[Pubmed] | [DOI]
6 Prise en charge de l’intoxication orale au phosphure d’aluminium
Brahim Boukatta,Abderrahim El Bouazzaoui,Nawfal Houari,Sanae Achour,Hicham Sbai,Nabil Kanjaa
Toxicologie Analytique et Clinique. 2014; 26(1): 39
[Pubmed] | [DOI]
7 Acute organophosphorus poisoning
Sheemona Chowdhary,Rajasri Bhattacharyya,Dibyajyoti Banerjee
Clinica Chimica Acta. 2014;
[Pubmed] | [DOI]
8 Use of continuous renal replacement therapy in acute aluminum phosphide poisoning: a novel therapy
Prashant Nasa,Ankur Gupta,Kishore Mangal,S.K. Nagrani,Sanjay Raina,Rohit Yadav
Renal Failure. 2013; 35(8): 1170
[Pubmed] | [DOI]
9 On the benefit of magnetic magnesium nanocarrier in cardiovascular toxicity of aluminum phosphide
Baeeri, M. and Shariatpanahi, M. and Baghaei, A. and Ghasemi-Niri, S.F. and Mohammadi, H. and Mohammadirad, A. and Hassani, S. and Bayrami, Z. and Hosseini, A. and Rezayat, S.M. and Abdollahi, M.
Toxicology and Industrial Health. 2013; 29(2): 126-135
[Pubmed]
10 Pesticide poisoning trend analysis of 13 years: A retrospective study based on telephone calls at the National Poisons Information Centre, All India Institute of Medical Sciences, New Delhi
Sharda Shah Peshin,Amita Srivastava,Nabanita Halder,Yogendra Kumar Gupta
Journal of Forensic and Legal Medicine. 2013;
[Pubmed] | [DOI]
11 Phosphide poisoning: A review of literature
Bumbrah, G.S., Krishan, K., Kanchan, T., Sharma, M., Sodhi, G.S.
Forensic Science International. 2012; 214(1-3): 1-6
[Pubmed]
12 Acute Aluminium Phosphide poisoning: Can we predict survival?
Sanaei-Zadeh, H.
Indian Journal of Anaesthesia. 2012; 56(2): 207-208
[Pubmed]
13 Phosphide poisoning: A review of literature
Gurvinder Singh Bumbrah,Kewal Krishan,Tanuj Kanchan,Madhulika Sharma,Gurvinder Singh Sodhi
Forensic Science International. 2012; 214(1-3): 1
[Pubmed] | [DOI]
14 A case of intoxication with zinc phosphide
Sadlik, J.K.
Z Zagadnien Nauk Sadowych. 2011; 88: 345-353
[Pubmed]
15 A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome
Shadnia, S., Mehrpour, O., Soltaninejad, K.
Indian Journal of Medical Sciences. 2010; 64(12): 532-539
[Pubmed]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Methods
    Results
    Discussion
    Acknowledgement
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed4823    
    Printed134    
    Emailed1    
    PDF Downloaded529    
    Comments [Add]    
    Cited by others 15    

Recommend this journal